Proposal to amend List A (List of certain antimicrobial active ingredients) – Proposed List A 2022

I. Proposed additions to List A

List A will be amended by inserting new antimicrobial active pharmaceutical ingredients and antibacterial classes listed below.

Proposed additions to List A
Drugs containing any of the following:

Including (but not limited to)

Aminoglycosides Fortimicin
Plazomicin
Beta-lactamase inhibitors Durlobactam
Enmetazobactam
Nacubactam
Relebactam
Taniborbactam
Zidebactam
Benzimidazoles Ridinilazole
Benzofuran naphthyridines Afabicin
Carbapenems Benapenem
Tebipenem pivoxil
Cephalosporins - fourth generation Cefiderocol
Diketopiperazines Bicyclomycin (Bicozamycin)
DNA polymerase inhibitors Ibezapolstat
Fluoroquinolones Alalevonadifloxacin
Antofloxacin
Aravofloxacin
Balofloxacin
Clinafloxacin
Levonadifloxacin
Zabofloxacin
Glycopeptides Cefilavancin
Norvancomycin
Ketolides Nafithromycin
Monobactams Ancremonam
Nitrofurans Nitrofurazone
Nitroimidazoles Morinidazole
Oxazolidinones Contezolid
Contezolid acefosamil
Delpazolid
Sutezolid
Penems Sulopenem etzadroxil
Peptidomimetics Brilacidin
Murepavaidin
Pleuromutilins Lefamulin
Quinolinols Nitroxoline
Quinolones Nemonoxacin
Spiropyrimidinetriones Zoliflodacin
Sulfonamides Sulfabenzamide
Tetracyclines - newer generations Eravacycline
Omadacycline
Sarecycline
Therapeutic agents for tuberculosis Clofazimine
Delaminid
Macozinone
Perchlozone
Pretomanid
Telacebec
Triazaacenaphthylenes Gepotidacin

II. Proposed revisions to existing antimicrobial active ingredients on List A

Proposed revisions to List A
Drugs containing any of the following: Including (but not limited to) Amendment (comments)
Aminoglycosides Apramycin Old drug (re-classify previously aminocyclitols)
Hygromycin B Old drug (re-classify previously aminocyclitols)

Page details

Date modified: